Report copyright - Silence Therapeutics · ° Disposal of the final portion of Arrowhead Pharmaceuticals shares in January 2018 with cumulative proceeds from the disposal totalling $24.7m (£18.4m)
Please pass captcha verification before submit form
Please pass captcha verification before submit form